Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate in Healthy Males”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01254071
What this trial is testing

Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 86
Early research (Phase 1)Study completedNCT07014488
What this trial is testing

Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 16
Early research (Phase 1)Study completedNCT01495026
What this trial is testing

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 63
Early research (Phase 1)Study completedNCT01471678
What this trial is testing

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 27
Early research (Phase 1)Study completedNCT00960310
What this trial is testing

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Who this might be right for
Prostate CancerHirsutism
Sandoz 36
Testing effectiveness (Phase 2)Looking for participantsNCT07202247
What this trial is testing

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Who this might be right for
Prostate CarcinomaRecurrent Prostate Carcinoma
City of Hope Medical Center 60
Early research (Phase 1)Study completedNCT03995888
What this trial is testing

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 24
Early research (Phase 1)WithdrawnNCT04879589
What this trial is testing

Phase 1 Study of ATRS-2002 in Healthy Male Adults

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Syneos Health
Early research (Phase 1)Study completedNCT02239484
What this trial is testing

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Who this might be right for
Erectile DysfunctionBenign Prostatic Hyperplasia
Hanmi Pharmaceutical Company Limited 30
Early research (Phase 1)Study completedNCT07404735
What this trial is testing

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Who this might be right for
Benign Prostate Hypertrophy(BPH)
Chong Kun Dang Pharmaceutical 34
Early research (Phase 1)Study completedNCT01497431
What this trial is testing

Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants

Who this might be right for
No Evidence of DiseaseProstate Carcinoma
National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT02417844
What this trial is testing

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

Who this might be right for
Prostatic Hyperplasia
Boehringer Ingelheim 34
Not applicableStudy completedNCT00923104
What this trial is testing

An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin

Who this might be right for
Breast CancerHealthy VolunteerProstate Cancer
National Cancer Institute (NCI) 61
Early research (Phase 1)Study completedNCT02417831
What this trial is testing

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

Who this might be right for
Prostatic Hyperplasia
Boehringer Ingelheim 34
Early research (Phase 1)Study completedNCT02352311
What this trial is testing

Safety and Pharmacokinetic Characteristics of DKF-313

Who this might be right for
Benign Prostate HyperplasiaHealthy
Dongkook Pharmaceutical Co., Ltd. 54
Not applicableStudy completedNCT02088164
What this trial is testing

Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 27,741
Not applicableStudy completedNCT00984919
What this trial is testing

Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 10
Early research (Phase 1)Study completedNCT00450957
What this trial is testing

Lycopene in Healthy Male Participants

Who this might be right for
Healthy, no Evidence of DiseaseProstate Cancer
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT03692585
What this trial is testing

Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital Behavior

Who this might be right for
Prostate CancerComputer LiteracyHealth Behavior
Danish Cancer Society 10
Not applicableStudy completedNCT05120973
What this trial is testing

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.

Who this might be right for
Prostate Cancer
The Netherlands Cancer Institute 26
Next Page